PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 2c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $50.1 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
• Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform